Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atypical/Malignant Meningioma”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Ended earlyNCT03016091
What this trial is testing

A Trial of Pembrolizumab for Refractory Atypical and Anaplastic Meningioma

Who this might be right for
Atypical MeningiomaAnaplastic MeningiomaHemangiopericytoma
Rabin Medical Center 18
Not applicableLooking for participantsNCT04501705
What this trial is testing

Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults

Who this might be right for
Recurrent Atypical/malignant Meningioma
Beijing Sanbo Brain Hospital 29
Not applicableActive Not RecruitingNCT01892397
What this trial is testing

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT03173950
What this trial is testing

Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Who this might be right for
MedulloblastomaEpendymomaPineal Region Tumors+2 more
National Cancer Institute (NCI) 133
Testing effectiveness (Phase 2)UnknownNCT00626730
What this trial is testing

Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 78
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Early research (Phase 1)Study completedNCT00007813
What this trial is testing

Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+5 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21
Not applicableUnknownNCT00349024
What this trial is testing

Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChordomaKidney Cancer+7 more
Children's Cancer and Leukaemia Group 50
Early research (Phase 1)Study completedNCT03434262
What this trial is testing

SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic EpendymomaAnaplastic Ganglioglioma+53 more
St. Jude Children's Research Hospital 68
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Not applicableUnknownNCT02973256
What this trial is testing

Oncological Care for Patients With Meningioma

Who this might be right for
Atypical MeningiomaClear-cell MeningiomaChordoid Meningioma+3 more
University Hospital, Montpellier 1,204
Testing effectiveness (Phase 2)Looking for participantsNCT02847559
What this trial is testing

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Who this might be right for
Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
Northwestern University 27
Testing effectiveness (Phase 2)Study completedNCT02234050
What this trial is testing

Trabectedin for Recurrent Grade II/III Meningioma

Who this might be right for
Recurrent High Grade Meningioma
European Organisation for Research and Treatment of Cancer - EORTC 90
Early research (Phase 1)Study completedNCT00303940
What this trial is testing

Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorKidney Cancer+5 more
National Institutes of Health Clinical Center (CC) 26
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT02648997
What this trial is testing

An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma

Who this might be right for
Meningiomas
Dana-Farber Cancer Institute 40
Early research (Phase 1)Looking for participantsNCT04541082
What this trial is testing

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Who this might be right for
Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more
Jazz Pharmaceuticals 102
Not applicableLooking for participantsNCT05793034
What this trial is testing

Predictive Factors for Survival in Aggressive Meningiomas

Who this might be right for
MeningiomaMeningioma AtypicalAnaplastic Meningioma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 250